Neurocrine Biosciences (CH:NB3)
NASDAQ:NB3
NB3 Analyst Ratings
Strong Buy
21 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NB3 Stock 12 Month Forecast
Average Price Target
$153.76
| Highest Price Target$198.79 | Average Price Target$153.76 | Lowest Price Target$116.36 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Jefferies
CHF146.26
Buy
―
Reiterated
06/16/26
Citi
CHF198.79
Buy
―
Reiterated
06/15/26
William Blair
―
Buy
―
Reiterated
06/02/26
Goldman Sachs
CHF172.12
Buy
―
Initiated
06/02/26
RBC Capital
CHF145.46→CHF147.88
Buy
―
Reiterated
05/29/26
Evercore ISI
CHF169.7
Buy
―
Reiterated
05/18/26
BMO Capital
CHF116.36
Hold
―
Reiterated
05/11/26
J.P. Morgan
CHF143.03→CHF149.5
Buy
―
Assigned
05/08/26
Deutsche Bank
CHF121.21→CHF125.25
Hold
―
Reiterated
05/07/26
Truist Financial
CHF125.25
Buy
―
Assigned
05/07/26
Oppenheimer
CHF177.78→CHF185.86
Buy
―
Assigned
05/06/26
Stifel Nicolaus
CHF151.92
Buy
―
Reiterated
05/06/26
Piper Sandler
CHF153.54→CHF167.27
Buy
―
Reiterated
05/06/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Jefferies
CHF146.26
Buy
―
Reiterated
06/16/26
Citi
CHF198.79
Buy
―
Reiterated
06/15/26
William Blair
―
Buy
―
Reiterated
06/02/26
Goldman Sachs
CHF172.12
Buy
―
Initiated
06/02/26
RBC Capital
CHF145.46→CHF147.88
Buy
―
Reiterated
05/29/26
Evercore ISI
CHF169.7
Buy
―
Reiterated
05/18/26
BMO Capital
CHF116.36
Hold
―
Reiterated
05/11/26
J.P. Morgan
CHF143.03→CHF149.5
Buy
―
Assigned
05/08/26
Deutsche Bank
CHF121.21→CHF125.25
Hold
―
Reiterated
05/07/26
Truist Financial
CHF125.25
Buy
―
Assigned
05/07/26
Oppenheimer
CHF177.78→CHF185.86
Buy
―
Assigned
05/06/26
Stifel Nicolaus
CHF151.92
Buy
―
Reiterated
05/06/26
Piper Sandler
CHF153.54→CHF167.27
Buy
―
Reiterated
05/06/26
Best Analysts Covering Neurocrine
3 Months
Success Rate
15/22 ratings generated profit
Average Return
+4.44%
Copying Tazeen Ahmad's trades and holding each position for 3 Months would result in 68.18% of your transactions generating a profit, with an average return of +4.44% per trade.
1 Year
Success Rate
17/23 ratings generated profit
Average Return
+10.14%
Copying Phil Nadeau's trades and holding each position for 1 Year would result in 73.91% of your transactions generating a profit, with an average return of +10.14% per trade.
2 Years
Success Rate
20/22 ratings generated profit
Average Return
+18.89%
Copying Tazeen Ahmad's trades and holding each position for 2 Years would result in 90.91% of your transactions generating a profit, with an average return of +18.89% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
NB3 Analyst Recommendation Trends
Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
7
7
10
7
8
Buy
45
29
27
26
28
Hold
5
4
6
8
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
57
40
43
41
44
Each month's total comprises the sum of three months' worth of ratings.
NB3 Financial Forecast
NB3 Stock Forecast FAQ
What is CH:NB3’s average 12-month price target, according to analysts?
Based on analyst ratings, Neurocrine Biosciences’s 12-month average price target is 153.76.
What is CH:NB3’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:NB3, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Neurocrine Biosciences a Buy, Sell or Hold?
Neurocrine Biosciences has a consensus rating of Strong Buy, which is based on 21 buy ratings, 3 hold ratings and 0 sell ratings.
What is Neurocrine Biosciences’s share price target?
The average share price target for Neurocrine Biosciences is 153.76. This is based on 24 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $198.79 ,and the lowest forecast is $116.36. The average share price target represents N/A Increase from the current price of N/A.
The highest analyst share price target is $198.79 ,and the lowest forecast is $116.36. The average share price target represents N/A Increase from the current price of N/A.
What do analysts say about Neurocrine Biosciences?
Neurocrine Biosciences’s analyst rating consensus is a Strong Buy. This is based on the ratings of 24 Wall Streets Analysts.
How can I buy shares of Neurocrine Biosciences?
To buy shares of CH:NB3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.